These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 16000082)
1. Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery. Thongboonkerd V Expert Rev Proteomics; 2005 Jun; 2(3):349-66. PubMed ID: 16000082 [TBL] [Abstract][Full Text] [Related]
2. [Proteomics and the kidney: an innovative approach to the study of renal disease]. Netti GS; Rocchetti MT; Papale M; Centra M; Centonze D; Di Paolo S; Ranieri E; Gesualdo L G Ital Nefrol; 2008; 25(2):169-82. PubMed ID: 18350497 [TBL] [Abstract][Full Text] [Related]
3. Proteomics in renal transplantation: opportunities and challenges. Schaub S; Wilkins JA; Nickerson P Clin Transpl; 2004; ():253-60. PubMed ID: 16704156 [TBL] [Abstract][Full Text] [Related]
4. Urinary proteomics: a tool to discover biomarkers of kidney diseases. Dihazi H; Müller GA Expert Rev Proteomics; 2007 Feb; 4(1):39-50. PubMed ID: 17288514 [TBL] [Abstract][Full Text] [Related]
5. Challenges of genomics and proteomics in nephrology. Stojnev S; Pejcic M; Dolicanin Z; Velickovic LJ; Dimov I; Stefanovic V Ren Fail; 2009; 31(8):765-72. PubMed ID: 19814648 [TBL] [Abstract][Full Text] [Related]
6. Better understanding of organ dysfunction requires proteomic involvement. Wang X; Adler KB; Chaudry IH; Ward PA J Proteome Res; 2006 May; 5(5):1060-2. PubMed ID: 16674094 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective. Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558 [TBL] [Abstract][Full Text] [Related]
8. Proteomic methods for biomarker discovery in urine. Wilkey DW; Merchant ML Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841 [TBL] [Abstract][Full Text] [Related]
9. Proteomic biomarker discovery for the monogenic disease cystic fibrosis. Penque D Expert Rev Proteomics; 2007 Apr; 4(2):199-209. PubMed ID: 17425456 [TBL] [Abstract][Full Text] [Related]
10. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. Calvo KR; Liotta LA; Petricoin EF Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423 [TBL] [Abstract][Full Text] [Related]
11. Oncoproteomics: current trends and future perspectives. Cho WC; Cheng CH Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924 [TBL] [Abstract][Full Text] [Related]
12. Urinary proteomics--a tool for biomarker discovery. Pejcic M; Stojnev S; Stefanovic V Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189 [TBL] [Abstract][Full Text] [Related]
14. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics. Phan JH; Quo CF; Wang MD Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692 [TBL] [Abstract][Full Text] [Related]
15. Proteomic approaches in lung cancer biomarker development. Cho JY; Sung HJ Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125 [TBL] [Abstract][Full Text] [Related]
16. Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for. Spasovski G; Ortiz A; Vanholder R; El Nahas M Proteomics Clin Appl; 2011 Jun; 5(5-6):233-40. PubMed ID: 21538916 [TBL] [Abstract][Full Text] [Related]
17. Proteomics in gerontology: current applications and future aspects--a mini-review. Schiffer E; Mischak H; Zimmerli LU Gerontology; 2009; 55(2):123-37. PubMed ID: 19136815 [TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of bone cancer: a review of current and future developments. Bhattacharyya S; Byrum S; Siegel ER; Suva LJ Expert Rev Proteomics; 2007 Jun; 4(3):371-8. PubMed ID: 17552921 [TBL] [Abstract][Full Text] [Related]